Literature DB >> 2154967

Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin.

E Ottnad1, D P Via, H Sinn, E Friedrich, R Ziegler, H A Dresel.   

Abstract

The binding characteristics of reduced hepatic membrane proteins for acetylated low-density lipoprotein (acetyl-LDL) and maleylated bovine serum albumin (Mal-BSA) have been examined. Two receptor activities were extracted from hepatic membranes in the presence of octyl beta-D-glucoside and beta-mercaptoethanol, and were separated by chromatography on Mal-BSA-Sepharose 4B. The receptors were revealed by ligand blotting. The active binding proteins had apparent molecular masses of 35 and 15 kDa in SDS/polyacrylamide gels. Equilibrium studies with protein-phosphatidylcholine complexes indicated that the reduced 35 kDa protein expresses two binding sites for Mal-BSA and one for acetyl-LDL, whereas the 15 kDa protein-phosphatidylcholine complex binds 131I-Mal-BSA and 131I-acetyl-LDL with a 4:1 stoichiometry. 131I-Mal-BSA binding was linear with both proteins, with a Kd of 4.8 nM at the 35 kDa protein and a Kd of 5.6 nM at the 15 kDa protein. The 35 kDa protein displayed saturable binding of 131I-acetyl-LDL with a Kd of 5 nM; the 15 kDa binding protein bound 131I-acetyl-LDL with a Kd of 2.3 nM. A 85 kDa protein was obtained by Mal-BSA-Sepharose chromatography when the hepatic membranes had been solubilized with Triton X-100 in presence of GSH/GSSG. This protein displayed saturable 131I-Mal-BSA binding with a Kd of 30 nM and 131I-acetyl-LDL binding with a Kd of 6.5 nM. The 131I-Mal-BSA binding capacity was four times higher than that of 131I-acetyl-LDL. Competition studies with the 35 kDa, 15 kDa and 85 kDa proteins binding Mal-BSA, acetyl-LDL, formylated albumin and polyanionic competitors provide evidence for the existence of more than one class of binding sites at the reduced binding proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154967      PMCID: PMC1133689          DOI: 10.1042/bj2650689

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent.

Authors:  H J Sinn; H H Schrenk; E A Friedrich; D P Via; H A Dresel
Journal:  Anal Biochem       Date:  1988-04       Impact factor: 3.365

2.  Purification and characterization of a bovine acetyl low density lipoprotein receptor.

Authors:  T Kodama; P Reddy; C Kishimoto; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Solubilization and purification of an acetyl-LDL binding membrane protein from human leukocytes.

Authors:  H A Dresel; G Schettler; D P Via
Journal:  Agents Actions Suppl       Date:  1984

4.  Evidence in liver for a disulphide-linked scavenger receptor containing a binding site for acetylated low-density lipoprotein and maleylated bovine serum albumin.

Authors:  E Ottnad; D P Via; H Sinn; E Friedrich; R Ziegler; H A Dresel
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

5.  Clearance of acetyl low density lipoprotein by rat liver endothelial cells. Implications for hepatic cholesterol metabolism.

Authors:  R Blomhoff; C A Drevon; W Eskild; P Helgerud; K R Norum; T Berg
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

6.  Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor.

Authors:  D P Via; H A Dresel; S L Cheng; A M Gotto
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

7.  Endocytosis of acetylated low-density lipoprotein, endothelial cell-modified low-density lipoprotein, and formaldehyde-treated serum albumin by rat liver endothelial cells. Evidence of uptake via a common receptor.

Authors:  W Eskild; T Henriksen; G Skretting; R Blomhoff; T Berg
Journal:  Scand J Gastroenterol       Date:  1987-12       Impact factor: 2.423

8.  Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells.

Authors:  R E Pitas; J Boyles; R W Mahley; D M Bissell
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

9.  Characterization of binding sites for acetylated low density lipoprotein in the rat liver in vivo and in vitro.

Authors:  H A Dresel; E Friedrich; D P Via; G Schettler; H Sinn
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

10.  Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors?

Authors:  H A Dresel; E Friedrich; D P Via; H Sinn; R Ziegler; G Schettler
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  7 in total

1.  Differentiation of binding sites on reconstituted hepatic scavenger receptors using oxidized low-density lipoprotein.

Authors:  E Ottnad; D P Via; J Frübis; H Sinn; E Friedrich; R Ziegler; H A Dresel
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 3.  Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family.

Authors:  Gerald J Mizejewski
Journal:  Tumour Biol       Date:  2010-12-01

4.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

5.  Hepatic uptake of a modified low molecular weight heparin in rats.

Authors:  G Stehle; E A Friedrich; H Sinn; A Wunder; J Harenberg; C E Dempfle; W Maier-Borst; D L Heene
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Mouse macrophage receptor for acetylated low density lipoprotein: demonstration of a fully functional subunit in the membrane and with purified receptor.

Authors:  D P Via; E S Kempner; L Pons; A E Fanslow; S Vignale; L C Smith; A M Gotto; H A Dresel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.